Werner's syndrome helicase participates in transcription of phenobarbital-inducible CYP2B genes in rat and mouse liver

Biochemical Pharmacology

Volumn 79, Issue 3, 2010, Pages 463-470

  Lachaud, Antoine Amaury ^a,b   Auclair Vincent, Sacha ^a,b   Massip, Laurent ^a,b   Audet Walsh, Étienne ^a,b   Lebel, Michel ^a,b   Anderson, Alan ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Chromatin immunoprecipitation; Gene regulation; Liver; Phenobarbital inducible genes; Transcription; Werner's syndrome

Indexed keywords

CYTOCHROME P450 2B; CYTOCHROME P450 2B10; CYTOCHROME P450 3A11; HELICASE; MESSENGER RNA; PHENOBARBITAL; UNCLASSIFIED DRUG; WERNER SYNDROME HELICASE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE MUTATION; GENETIC TRANSCRIPTION; HOMOZYGOSITY; LIVER; MALE; MICROSOME; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; RAT; RNA ANALYSIS; RNA ISOLATION; WERNER SYNDROME; WESTERN BLOTTING; WILD TYPE;

EID: 70449646216     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.09.002     Document Type: Article

References (61)

1. Martin G.M. Genetic modulation of senescent phenotypes in Homo sapiens. Cell 120 (2005) 523-532
2. Epstein C.J., and Motulsky A.G. Werner syndrome: entering the helicase era. Bioessays 18 (1996) 1025-1027
3. Goto M. Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 98 (1997) 239-254
4. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., et al. Positional cloning of the Werner's syndrome gene. Science 272 (1996) 258-262
5. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., et al. The Werner syndrome protein is a DNA helicase. Nat Genet 17 (1997) 100-103
6. Imamura O., Ichikawa K., Yamabe Y., Goto M., Sugawara M., and Furuichi Y. Cloning of a mouse homologue of the human Werner syndrome gene and assignment to 8A4 by fluorescence in situ hybridization. Genomics 41 (1997) 298-300
7. Kamath-Loeb A.S., Shen J.C., Loeb L.A., and Fry M. Werner syndrome protein. II. Characterization of the integral 3′ → 5′ DNA exonuclease. J Biol Chem 273 (1998) 34145-34150
8. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., and Loeb L.A. Werner syndrome protein. I. DNA helicase and DNA exonuclease reside on the same polypeptide. J Biol Chem 273 (1998) 34139-34144
9. Kudlow B.A., Kennedy B.K., and Monnat Jr. R.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 8 (2007) 394-404
10. Huang S., Lee L., Hanson N.B., Lenaerts C., Hoehn H., Poot M., et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 27 (2006) 558-567
11. Navarro C.L., Cau P., and Levy N. Molecular bases of progeroid syndromes. Hum Mol Genet 15 (2006) R151-R161
12. Bohr V.A. Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem Sci 33 (2008) 609-620
13. Balajee A.S., Machwe A., May A., Gray M.D., Oshima J., Martin G.M., et al. The Werner syndrome protein is involved in RNA polymerase II transcription. Mol Biol Cell 10 (1999) 2655-2668
14. Kyng K.J., May A., Kolvraa S., and Bohr V.A. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc Natl Acad Sci USA 100 (2003) 12259-12264
15. Turaga R.V., Paquet E.R., Sild M., Vignard J., Garand C., Johnson F.B., et al. The Werner syndrome protein affects the expression of genes involved in adipogenesis and inflammation in addition to cell cycle and DNA damage responses. Cell Cycle 8 (2009) 2080-2092
16. Kyng K., Croteau D.L., and Bohr V.A. Werner syndrome resembles normal aging. Cell Cycle 8 (2009) 2323
17. Kwan P., and Brodie M.J. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45 (2004) 1141-1149
18. Okey A.B. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45 (1990) 241-298
19. Waxman D.J., and Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281 (1992) 577-592
20. Christou M., Wilson N.M., and Jefcoate C.R. Expression and function of three cytochrome P-450 isozymes in rat extrahepatic tissues. Arch Biochem Biophys 258 (1987) 519-534
21. Wilson N.M., Christou M., and Jefcoate C.R. Differential expression and function of three closely related phenobarbital-inducible cytochrome P-450 isozymes in untreated rat liver. Arch Biochem Biophys 256 (1987) 407-420
22. Anderson A. The induction of CYP2B proteins in rodents by phenobarbital-like inducers: what has been discovered and what remains to be learned. Acta Chim Slov 55 (2008) 45-52
23. Honkakoski P., Auriola S., and Lang M.A. Distinct induction profiles of 3 phenobarbital-responsive mouse liver cytochrome-P450 isozymes. Biochem Pharmacol 43 (1992) 2121-2128
24. Hardwick J.P., Gonzalez F.J., and Kasper C.B. Transcriptional regulation of rat liver epoxide hydratase, NADPH-cytochrome P-450 oxidoreductase, and cytochrome P-450b genes by phenobarbital. J Biol Chem 258 (1983) 8081-8085
25. Rencurel F., Foretz M., Kaufmann M.R., Stroka D., Looser R., Leclerc I., et al. Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol 70 (2006) 1925-1934
26. Sueyoshi T., and Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41 (2001) 123-143
27. Trottier E., Belzil A., Stoltz C., and Anderson A. Localization of a phenobarbital responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158 (1995) 263-268
28. Stoltz C., Vachon M.-H., Trottier E., Dubois S., Paquet Y., and Anderson A. The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J Biol Chem 273 (1998) 8528-8536
29. Hirsch-Ernst K.I., Schlaefer K., Bauer D., Heder A.F., and Kahl G.F. Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures. Mol Pharmacol 59 (2001) 1402-1409
30. Honkakoski P., and Negishi M. Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 272 (1997) 14943-14949
31. Paquet Y., Trottier E., Beaudet M.-J., and Anderson A. Mutational analysis of the CYP2B2 phenobarbital response unit and inhibitory effect of the constitutive androstane receptor on phenobarbital responsiveness. J Biol Chem 275 (2000) 38427-38436
32. Honkakoski P., Moore R., Washburn K.A., and Negishi M. Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol Pharmacol 53 (1998) 597-601
33. Beaudet M.-J., Desrochers M., Lachaud A.A., and Anderson A. The CYP2B2 phenobarbital response unit contains binding sites for hepatocyte nuclear protein 4, PBX-PREP1, the thyroid receptor, and the liver X receptor. Biochem J 388 (2005) 407-418
34. Honkakoski P., Zelko I., Sueyoshi T., and Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18 (1998) 5652-5658
35. Tzameli I., Pissios P., Schuetz E.G., and Moore D.D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20 (2000) 2951-2958
36. Zhang Q., Bae Y., Kemper J.K., and Kemper B. Analysis of multiple nuclear receptor binding sites for CAR/RXR in the phenobarbital responsive unit of CYP2B2. Arch Biochem Biophys 451 (2006) 119-127
37. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., and Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19 (1999) 6318-6322
38. Wei P., Zhang J., Egan-Hafley M., Liang S., and Moore D.D. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407 (2000) 920-923
39. Lebel M., and Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci USA 95 (1998) 13097-13102
40. Jean A., Rivkin E., and Anderson A. Simple sequence DNA associated with near sequence identity of the 3′-flanking regions of rat cytochrome P450b and P450e genes. DNA 7 (1988) 361-369
41. Wrighton S.A., Schuetz E.G., Watkins P.B., Maurel P., Barwick J., Bailey B.S., et al. Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat. Mol Pharmacol 28 (1985) 312-321
42. Cherrington N.J., Slitt A.L., Maher J.M., Zhang X.X., Zhang J., Huang W., et al. Induction of multidrug resistance protein 3 (MRP3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos 31 (2004) 1315-1319
43. Desrochers M., Christou M., Jefcoate C., Belzil A., and Anderson A. New proteins in the rat CYP2B subfamily: presence in liver microsomes of the constitutive CYP2B3 protein and the phenobarbital-inducible protein product of alternatively spliced CYP2B2 mRNA. Biochem Pharmacol 52 (1996) 1311-1319
44. Waxman D.J. Rat hepatic cytochrome P-450 isoenzyme 2c. Identification as a male-specific, developmentally induced steroid 16-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J Biol Chem 259 (1984) 15481-15490
45. Wiwi C.A., Gupte M., and Waxman D.J. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4-deficient mice. Mol Endocrinol 18 (2004) 1975-1987
46. Leenders F., Adamski J., Husen B., Thole H.H., and Jungblut P.W. Molecular cloning and amino acid sequence of the porcine 17-estradiol dehydrogenase. Eur J Biochem 222 (1994) 221-227
47. Renwick A.G., Soon C.Y., Chambers S.M., and Brown C.R. Estradiol-17 dehydrogenase from chicken liver. J Biol Chem 256 (1981) 1881-1887
48. Henderson L.L., and Warren J.C. Purification and characterization of epimeric estradiol dehydrogenases (17 and 17) from equine placenta. Biochemistry 23 (1984) 486-491
49. Chaya D., and Zaret K.S. Sequential chromatin immunoprecipitation from animal tissues. Methods Enzymol 376 (2004) 361-372
50. Seglen P.O. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82 (1973) 391-398
51. Massip L., Garand C., Turaga R.V., Deschenes F., Thorin E., and Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. Exp Gerontol 41 (2006) 157-168
52. Anakk S., Kalsotra A., Kikuta Y., Huang W., Zhang J., Staudinger J.L., et al. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenom J 4 (2004) 91-101
53. Hartley D.P., and Klaassen C.D. Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology. Drug Metab Dispos 28 (2005) 608-616
54. Cheng W.H., von Kobbe C., Opresko P.L., Fields K.M., Ren J., Kufe D., et al. Werner syndrome protein phosphorylation by Abl tyrosine kinase regulates its activity and distribution. Mol Cell Biol 23 (2003) 6385-6395
55. Opresko P.L., Cheng W.H., von Kobbe C., Harrigan J.A., and Bohr V.A. Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 24 (2003) 791-802
56. Blander G., Kipnis J., Leal J.F., Yu C.E., Schellenberg G.D., and Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. J Biol Chem 274 (1999) 29463-29469
57. Park Y., and Kemper B. The CYP2B1 proximal promoter contains a functional C/EBP regulatory element. DNA Cell Biol 15 (1996) 693-701
58. Luc P-VT, Adesnik M., Ganguly S., and Shaw P.M. Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins. Biochem Pharmacol 51 (1996) 345-356
59. Kusumoto R., Muftuoglu M., and Bohr V.A. The role of WRN in DNA repair is affected by post-translational modifications. Mech Ageing Dev 128 (2007) 50-57
60. von Kobbe C., Thoma N.H., Czyzewski B.K., Pavletich N.P., and Bohr V.A. Werner syndrome protein contains three structure-specific DNA binding domains. J Biol Chem 278 (2003) 52997-53006
61. Shen J.C., and Loeb L.A. Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA. Nucleic Acids Res 28 (2000) 3260-3268